These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 2814914)
1. [The importance of software for the planning and adjusting of dosage. Application with aminoglycosides]. Brouard A; Hubert I; Baud F; Clavier N; Galliot M; Bismuth C; Terriér JL Therapie; 1989; 44(5):331-6. PubMed ID: 2814914 [TBL] [Abstract][Full Text] [Related]
2. Experience with a once-daily dosing program of aminoglycosides in critically ill patients. Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533 [TBL] [Abstract][Full Text] [Related]
3. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation. Garrelts JC Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474 [TBL] [Abstract][Full Text] [Related]
4. Design of initial dosage regimen using a programmable calculator. Ritschel WA; Eldon MA Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):383-91. PubMed ID: 3840551 [TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin. Hermida J; Tutor JC Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715 [TBL] [Abstract][Full Text] [Related]
6. An aminoglycoside dosing program using the Casio FX-700P pocket computer. Yutani RM Hosp Pharm; 1985 Jun; 20(6):416, 421-3, 426. PubMed ID: 10278328 [TBL] [Abstract][Full Text] [Related]
7. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients. Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157 [TBL] [Abstract][Full Text] [Related]
8. Once-daily versus multiple-daily dosing of aminoglycosides. Craig WA J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic variability of extended interval tobramycin in burn patients. Bracco D; Landry C; Dubois MJ; Eggimann P Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988 [TBL] [Abstract][Full Text] [Related]
10. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
11. National survey of extended-interval aminoglycoside dosing. Chuck SK; Raber SR; Rodvold KA; Areff D Clin Infect Dis; 2000 Mar; 30(3):433-9. PubMed ID: 10722424 [TBL] [Abstract][Full Text] [Related]
12. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. Dager WE; King JH Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944 [TBL] [Abstract][Full Text] [Related]
13. Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens. McCormack JP; Schentag JJ Drug Intell Clin Pharm; 1987 Feb; 21(2):187-92. PubMed ID: 3829911 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients. Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form. Schuck EL; Dalhoff A; Stass H; Derendorf H Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708 [TBL] [Abstract][Full Text] [Related]
16. Increased amikacin dosage requirements in burn patients receiving a once-daily regimen. Conil JM; Georges B; Breden A; Segonds C; Lavit M; Seguin T; Coley N; Samii K; Chabanon G; Houin G; Saivin S Int J Antimicrob Agents; 2006 Sep; 28(3):226-30. PubMed ID: 16908121 [TBL] [Abstract][Full Text] [Related]
17. Tobramycin population pharmacokinetics in neonates. de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390 [TBL] [Abstract][Full Text] [Related]
18. Vancomycin population pharmacokinetics in neonates. de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244 [TBL] [Abstract][Full Text] [Related]
19. [Validation of a new interactive software monitoring a controlled-flow infusion pump for cisplatin dosage regimen adjustment]. Cupissol D; Brès J; Gestin-Boyer C; Nouguier-Soulé J; Vian L; Tep A; Nouguier J Bull Cancer; 1996 Aug; 83(8):664-76. PubMed ID: 8869047 [TBL] [Abstract][Full Text] [Related]